IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,418,440 | -23.5% | 141,500 | -30.8% | 0.02% | -24.0% |
| Q2 2023 | $8,386,532 | +144.7% | 204,400 | +113.2% | 0.02% | +127.3% |
| Q1 2023 | $3,426,930 | +602.2% | 95,885 | +627.2% | 0.01% | +450.0% |
| Q2 2022 | $488,000 | -70.3% | 13,185 | -75.6% | 0.00% | -71.4% |
| Q4 2021 | $1,643,000 | -77.7% | 53,981 | -75.4% | 0.01% | -78.1% |
| Q3 2021 | $7,355,000 | -81.1% | 219,300 | -77.6% | 0.03% | -81.7% |
| Q2 2021 | $38,969,000 | +71.3% | 976,900 | +142.8% | 0.18% | +57.7% |
| Q4 2020 | $22,752,000 | +66.2% | 402,400 | +39.5% | 0.11% | +58.6% |
| Q3 2020 | $13,689,000 | +33.0% | 288,492 | +65.2% | 0.07% | +4.5% |
| Q2 2020 | $10,296,000 | +3814.8% | 174,625 | +3033.4% | 0.07% | +3250.0% |
| Q1 2020 | $263,000 | -94.1% | 5,573 | -93.5% | 0.00% | -88.9% |
| Q3 2018 | $4,437,000 | +249.9% | 86,031 | +244.1% | 0.02% | +200.0% |
| Q3 2017 | $1,268,000 | -61.2% | 25,000 | -69.0% | 0.01% | -76.0% |
| Q1 2016 | $3,264,000 | -82.3% | 80,600 | -72.9% | 0.02% | -83.6% |
| Q4 2015 | $18,449,000 | – | 297,900 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |